TC-E 5001Potent tankyrase inhibitor CAS# 865565-29-3 |
2D Structure
- Nadifloxacin
Catalog No.:BCC4804
CAS No.:124858-35-1
- Calcipotriol monohydrate
Catalog No.:BCC1445
CAS No.:147657-22-5
- Halobetasol Propionate
Catalog No.:BCC4664
CAS No.:66852-54-8
- Dihydroartemisinin
Catalog No.:BCN6264
CAS No.:71939-50-9
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 865565-29-3 | SDF | Download SDF |
PubChem ID | 16013184 | Appearance | Powder |
Formula | C20H19N5O3S | M.Wt | 409.46 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 100 mM in DMSO | ||
Chemical Name | 3-(4-methoxyphenyl)-5-[[4-(4-methoxyphenyl)-5-methyl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole | ||
SMILES | CC1=NN=C(N1C2=CC=C(C=C2)OC)SCC3=NC(=NO3)C4=CC=C(C=C4)OC | ||
Standard InChIKey | LQZSHPITKSPDLC-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C20H19N5O3S/c1-13-22-23-20(25(13)15-6-10-17(27-3)11-7-15)29-12-18-21-19(24-28-18)14-4-8-16(26-2)9-5-14/h4-11H,12H2,1-3H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Dual tankyrase (TNKS) inhibitor (Kd values are 79 and 28 nM for TNKS1 and TNKS2 respectively, IC50 = 33 nM for TNKS2) that is devoid of activity at PARP1 and PARP2 (IC50 >19 μM). Inhibits Wnt signaling and stabilizes Axin2 levels. |
TC-E 5001 Dilution Calculator
TC-E 5001 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.4422 mL | 12.2112 mL | 24.4224 mL | 48.8448 mL | 61.056 mL |
5 mM | 0.4884 mL | 2.4422 mL | 4.8845 mL | 9.769 mL | 12.2112 mL |
10 mM | 0.2442 mL | 1.2211 mL | 2.4422 mL | 4.8845 mL | 6.1056 mL |
50 mM | 0.0488 mL | 0.2442 mL | 0.4884 mL | 0.9769 mL | 1.2211 mL |
100 mM | 0.0244 mL | 0.1221 mL | 0.2442 mL | 0.4884 mL | 0.6106 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Ganoderic acid SZ
Catalog No.:BCN4413
CAS No.:865543-37-9
- Junipediol A
Catalog No.:BCN6912
CAS No.:86548-91-6
- 5-R-Rivaroxaban
Catalog No.:BCC1313
CAS No.:865479-71-6
- Bisisorhapontigenin A
Catalog No.:BCN3501
CAS No.:865474-98-2
- Narlaprevir
Catalog No.:BCC1785
CAS No.:865466-24-6
- apigenin 7-O-(6〃-O-malonyl)-β-D-glucoside
Catalog No.:BCN8399
CAS No.:86546-87-4
- Benazepril
Catalog No.:BCC4286
CAS No.:86541-75-5
- Benazepril HCl
Catalog No.:BCC5019
CAS No.:86541-74-4
- N-Methylcalycinine
Catalog No.:BCN4412
CAS No.:86537-66-8
- FR 180204
Catalog No.:BCC3669
CAS No.:865362-74-9
- 4,5-dihydroxy-3,8-dimethylnaphthalene-1,2-dione
Catalog No.:BCN8422
CAS No.:86533-36-0
- AMG837
Catalog No.:BCC6387
CAS No.:865231-46-5
- 2-[(6-Chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]benzonitrile
Catalog No.:BCC8506
CAS No.:865758-96-9
- Trelagliptin
Catalog No.:BCC2014
CAS No.:865759-25-7
- PF-03084014
Catalog No.:BCC1848
CAS No.:865773-15-5
- Cytochrome c - pigeon (88-104)
Catalog No.:BCC1038
CAS No.:86579-06-8
- RX-3117
Catalog No.:BCC6381
CAS No.:865838-26-2
- Chamaejasmenin D
Catalog No.:BCN3046
CAS No.:865852-47-7
- Isochamaejasmenin B
Catalog No.:BCN3045
CAS No.:865852-48-8
- Tideglusib
Catalog No.:BCC4511
CAS No.:865854-05-3
- Oleuropeic acid 8-O-glucoside
Catalog No.:BCN4025
CAS No.:865887-46-3
- L-745,870 trihydrochloride
Catalog No.:BCC5695
CAS No.:866021-03-6
- 6-Benzoyl-5,7-dihydroxy-2,2-dimethylchromane
Catalog No.:BCN1326
CAS No.:86606-14-6
- Clausine Z
Catalog No.:BCN4414
CAS No.:866111-14-0
[1,2,4]triazol-3-ylsulfanylmethyl)-3-phenyl-[1,2,4]oxadiazoles: antagonists of the Wnt pathway that inhibit tankyrases 1 and 2 via novel adenosine pocket binding.[Pubmed:22260203]
J Med Chem. 2012 Feb 9;55(3):1127-36.
The Wnt signaling pathway is critical to the regulation of key cellular processes. When deregulated, it has been shown to play a crucial role in the growth and progression of multiple human cancers. The identification of small molecule modulators of Wnt signaling has proven challenging, largely due to the relative paucity of druggable nodes in this pathway. Several recent publications have identified small molecule inhibitors of the Wnt pathway, and tankyrase (TNKS) inhibition has been demonstrated to antagonize Wnt signaling via axin stabilization. Herein, we report the early hit assessment of a series of compounds previously reported to antagonize Wnt signaling. We report the biophysical, computational characterization, structure-activity relationship, and physicochemical properties of a novel series of [1,2,4]triazol-3-ylsulfanylmethyl)-3-phenyl-[1,2,4]oxadiazole inhibitors of TNKS1 and 2. Furthermore, a cocrystal structure of compound 24 complexed to TNKS1 demonstrates an alternate binding mode for PARP family member proteins that does not involve interactions with the nicotinamide binding pocket.